AMERICAN INTERNATIONAL GROUP, INC. - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 123 filers reported holding KALA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$34,000
+9.7%
24,325
-5.3%
0.00%
Q4 2021$31,000
-55.1%
25,696
-2.9%
0.00%
Q3 2021$69,000
-52.1%
26,464
-2.3%
0.00%
Q2 2021$144,000
-7.1%
27,093
+17.4%
0.00%
-100.0%
Q1 2021$155,000
-0.6%
23,069
+0.3%
0.00%0.0%
Q4 2020$156,000
-12.4%
23,008
-2.8%
0.00%0.0%
Q3 2020$178,000
-29.9%
23,667
-2.2%
0.00%0.0%
Q2 2020$254,000
+106.5%
24,207
+72.4%
0.00%0.0%
Q1 2020$123,000
+141.2%
14,042
+0.7%
0.00%
Q4 2019$51,000
-1.9%
13,942
+1.1%
0.00%
Q3 2019$52,000
-41.6%
13,789
-0.7%
0.00%
Q2 2019$89,000
+6.0%
13,885
+35.9%
0.00%
Q1 2019$84,000
+64.7%
10,214
-1.5%
0.00%
Q4 2018$51,000
-32.9%
10,369
+34.3%
0.00%
Q3 2018$76,000
-26.9%
7,723
+1.8%
0.00%
Q2 2018$104,000
-27.8%
7,583
-16.8%
0.00%
-100.0%
Q1 2018$144,000
+60.0%
9,119
+86.6%
0.00%
Q4 2017$90,000
-26.2%
4,887
-8.1%
0.00%
Q3 2017$122,0005,3200.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,333,333$5,073,000100.00%
CAXTON CORP 1,483,343$5,644,0006.36%
Polaris Venture Management Co. V, L.L.C. 1,197,032$4,555,0002.59%
RA Capital Management 4,537,478$17,265,0001.03%
Orbimed Advisors 3,447,840$13,119,0000.25%
Matisse Capital 46,500$177,0000.22%
PURA VIDA INVESTMENTS, LLC 332,831$1,266,0000.22%
Sofinnova Investments, Inc. 478,206$1,819,0000.16%
HARBOURVEST PARTNERS LLC 99,186$377,0000.16%
ALGERT GLOBAL LLC 47,195$180,0000.07%
View complete list of KALA PHARMACEUTICALS INC shareholders